Furthermore, CD109 maintains cancer stem-like properties or promotes tumorigenicity and metastasis by interacting with EGFR in lung adenocarcinoma, cervical squamous cell carcinoma, and HNSCC [14,28,32]. This evidence concerns the gene CD109 and head and neck squamous cell carcinoma.